APA (7th ed.) Citation

Wu, P., Li, D., Zhang, C., Sun, N., & He, J. (2025). Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant? Journal of thoracic oncology, 20(3), e41-e42. https://doi.org/10.1016/j.jtho.2024.11.017

Chicago Style (17th ed.) Citation

Wu, Peng, Dongyu Li, Chaoqi Zhang, Nan Sun, and Jie He. "Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?" Journal of Thoracic Oncology 20, no. 3 (2025): e41-e42. https://doi.org/10.1016/j.jtho.2024.11.017.

MLA (9th ed.) Citation

Wu, Peng, et al. "Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?" Journal of Thoracic Oncology, vol. 20, no. 3, 2025, pp. e41-e42, https://doi.org/10.1016/j.jtho.2024.11.017.